A Comparison of Mood Improvements Following a Single Infusion of an N-methyl-D-aspartate (NMDA) Antagonist in Treatment-Resistant Patients with Anxious and Non-Anxious Depression

被引：0
|
作者：
Ionescu, Dawn F. [1 ]
Luckenbaugh, David A. [1 ]
Slonena, Elizabeth E. [1 ]
Niciu, Mark J. [1 ]
Richards, Erica M. [1 ]
Zarate, Carlos A. [1 ]
机构：
[1] NIMH, NIH, Bethesda, MD 20892 USA
来源：
BIOLOGICAL PSYCHIATRY | 2014年 / 75卷 / 09期
关键词：
Anxious Depression; Ketamine; Treatment Resistant Depression;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
397
引用
收藏
页码：127S / 128S
页数：2
相关论文
共 42 条
  • [31] NEURONAL VACUOLE FORMATION IN THE RAT POSTERIOR CINGULATE RETROSPLENIAL CORTEX AFTER TREATMENT WITH THE N-METHYL-D-ASPARTATE (NMDA) ANTAGONIST MK-801 (DIZOCILPINE MALEATE)
    FIX, AS
    HORN, JW
    TRUEX, LL
    SMITH, RA
    GOMEZ, E
    ACTA NEUROPATHOLOGICA, 1994, 88 (06) : 511 - 519
  • [32] Single-dose infusion ketamine and non-ketamine N-methyl-D-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories
    Kishimoto, T.
    Chawla, J. M.
    Hagi, K.
    Zarate, C. A., Jr.
    Kane, J. M.
    Bauer, M.
    Correll, C. U.
    PSYCHOLOGICAL MEDICINE, 2016, 46 (07) : 1459 - 1472
  • [33] Cold allodynia and hyperalgesia in neuropathic pain:: the effect of N-methyl-D-aspartate (NMDA) receptor antagonist ketamine -: a double-blind, cross-over comparison with alfentanil and placebo
    Jorum, E
    Warncke, T
    Stubhaug, A
    PAIN, 2003, 101 (03) : 229 - 235
  • [34] Glutamate N-methyl-D-aspartate (NMDA) and non-NMDA receptor antagonists administered into the brain stem depress the renal sympathetic reflex discharges evoked by single shock of somatic afferents in anesthetized rats
    Nagata, O
    Li, WM
    Sato, A
    NEUROSCIENCE LETTERS, 1995, 201 (02) : 111 - 114
  • [35] Prevalence of N-Methyl-D-Aspartate Receptor antibody (NMDAR-Ab) encephalitis in patients with first episode psychosis and treatment resistant schizophrenia on clozapine, a population based study
    Kelleher, Eric
    McNamara, Patricia
    Dunne, Jean
    Fitzmaurice, Brian
    Heron, Elizabeth A.
    Whitty, Peter
    Walsh, Richard
    Mooney, Christina
    Hogan, Denise
    Conlon, Niall
    Gill, Michael
    Vincent, Angela
    Doherty, Colin P.
    Corvin, Aiden
    SCHIZOPHRENIA RESEARCH, 2020, 222 : 455 - 461
  • [36] Binding characterization of N-(2-chloro-5-thiomethylphenyl)- N′-(3-[3H]3 methoxy phenyl)-N′-methylguanidine ([3H]GMOM), a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist
    Metaxas, Athanasios
    van Berckel, Bart N. M.
    Klein, Pieter J.
    Verbeek, Joost
    Nash, Emily C.
    Kooijman, Esther J. M.
    Renjaan, Veronique A.
    Golla, Sandeep S., V
    Boellaard, Ronald
    Christiaans, Johannes A. M.
    Windhorst, Albert D.
    Leysen, Josee E.
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2019, 7 (01):
  • [37] Comparative Effects of LY3020371, a Potent and Selective Metabotropic Glutamate (mGlu) 2/3 Receptor Antagonist, and Ketamine, a Noncompetitive N-Methyl-D-Aspartate Receptor Antagonist in Rodents: Evidence Supporting the Use of mGlu2/3 Antagonists, for the Treatment of Depression.
    Witkin, J. M.
    Mitchell, S. N.
    Wafford, K. A.
    Carter, G.
    Gilmour, G.
    Li, J.
    Eastwood, B. J.
    Overshiner, C.
    Li, X.
    Rorick-Kehn, L.
    Rasmussen, K.
    Anderson, W. H.
    Nikolayev, A.
    Tolstikov, V. V.
    Kuo, M. -S.
    Catlow, J. T.
    Li, R.
    Smith, S. C.
    Mitch, C. H.
    Ornstein, P. L.
    Swanson, S.
    Monn, J. A.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2017, 361 (01): : 68 - 86
  • [38] An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder
    Preskorn, Sheldon H.
    Baker, Bryan
    Kolluri, Sheela
    Menniti, Frank S.
    Krams, Michael
    Landen, Jaren W.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2008, 28 (06) : 631 - 637
  • [39] Comments on "An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder"
    Hashimoto, Kenji
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2009, 29 (04) : 411 - 412
  • [40] ANTINOCICEPTION INDUCED BY 3-((PLUS-OR-MINUS)-2-CARBOXYPIPERAZIN-4-YL)-PROPYL-1-PHOSPHONIC ACID (CPP), AN N-METHYL-D-ASPARTATE (NMDA) COMPETITIVE ANTAGONIST, PLUS 6,7-DINITROQUINOXALINE-2,3-DIONE (DNQX), A NON-NMDA ANTAGONIST, DIFFERS FROM THAT INDUCED BY MK-801 PLUS DNQX
    GOETTL, VM
    LARSON, AA
    BRAIN RESEARCH, 1994, 642 (1-2) : 334 - 338
12345